We will further study these serum protein levels of the tPA–BDNF pathway in these mental disorders to determine the utility of this biomarker panel for differentiating MDD from other psychiatric disorders and identifying subgroups of patients with MDD. The gene discussed is BDNF; the disease is mental disorder.